Delivery Order SPE2DB20D9226-SPE2DB25FD1BX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,122.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation. DMS Pharmaceutical Group is performing at its Park Ridge facility and delivering...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $34,244.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector vials. The contract, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, was awarded without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,136.66 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml autoinjector on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, was issued without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL. The award...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, issued on September 3, 2025, with completion targeted for September 24, 2025, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The company,...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Xolair 300 mg/2 mL auto-injector vials valued at $3,424.46. The award, issued on September 3, 2025, with a completion date of September 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group, based in Park Ridge, Illinois, will perform the delivery at its location. This delivery order falls...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $8,561.15 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The delivery order, which is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, is for the delivery of 4,566,831,826 units of Xolair 300 mg/2 ml autoinjectors. This contract is not associated with any set-aside designation. As a key supplier in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,273.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL auto-injector vials. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, represents a specific pharmaceutical procurement supporting military healthcare operations. The award carries no...
- The Defense Logistics Agency has awarded a delivery order valued at $1,712.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml auto-injectors. This firm fixed-price delivery order, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, represents a specific product draw against DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The award...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $30,948.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of Xolair 150 mg/ml syringes, a specialty pharmaceutical product, with a period of performance through June 11, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $9,284.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/mL syringes and has an ultimate completion date of December 19, 2022. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription drugs, over-the-counter...
- SPE2DB20D9226Indefinite Delivery Contract
- SPE2DB20D9226-SPE2DB25FD1BXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,712.23 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 mL auto-injector vials. This firm fixed-price delivery order, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a single product shipment under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The contract utilizes no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its status as a woman-owned small business. The pharmaceutical products will be delivered to Park Ridge, Illinois, where the vendor maintains its headquarters and primary distribution operations. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, holds a significant single-award indefinite delivery contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. This overarching contract, awarded under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities nationwide. As a critical supplier in the federal pharmaceutical supply chain since its SAM.gov registration in 2001, DMS Pharmaceutical Group provides branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to military and federal healthcare systems, with this current delivery order representing routine fulfillment of medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/23/25 |